The high costs of vulvodynia are personal-and public
In addition to the high personal costs to women who have vulvodynia, the disorder imposes a financial burden on the US economy.
The annual per-patient cost of vulvodynia is more than $17,700 in direct and indirect medical expenses and non-healthcare expenses.
In addition to the financial burden, patients experience impaired quality of life and vulvodynia-related comorbidities.
Vulvodynia has a price tag exceeding $17,700 per patient per year. With a prevalence of 3% to 7% in reproductive-age women in the United States, the condition imposes a national annual financial burden of $31 billion to $72 billion, according to a recent Tulane University study.
Published in Current Medical Research and Opinion (2012;28[4]:1-8], the study used answers to a Web-based survey from 302 women who supplied information on at least 1 month. Of those, 97 supplied 6 months’ data.
Total costs over 6 months were $8,862.40 per patient. Most (68.19%) of that total consisted of direct healthcare costs, including insurance payments, medical treatment, lab work, and out-of-pocket expenses; 6.25% represented direct non-healthcare costs, including transportation and parking expenses; and 25.56% consisted of indirect costs, including financial loss from missed work and the inability to perform household chores.
According to the survey, one-third of the women had generalized vulvodynia, 40% had vestibulodynia, and 28% had both. On average, the women had experienced symptoms for 7 years. Eighty-six percent experienced severe pain on contact to the genital area; 76% experienced burning for 3 months or more; 91% experienced ≥10 episodes of pain on contact, and 95% reported limitation in intercourse.
Frequently reported comorbidities included irritable bowel syndrome, migraine headaches, temporomandibular disorders, interstitial cystitis, and endometriosis. The average Euro QOL 5 dimensions survey score for the women was 0.74±0.19 (mean±SD), which was lower than for kidney transplant recipients (0.87± 0.13) and individuals who have had an osteoporosis fracture (0.85±0.14).
Read other articles in this issue of Special Delivery
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
